首页 | 本学科首页   官方微博 | 高级检索  
     


Compassionate access anti‐tumour necrosis factor‐α therapy for ulcerative colitis in Australia: the benefits to patients
Authors:S. P. Costello  S. Ghaly  L. Beswick  A. Pudipeddi  A. Agarwal  A. Sechi  S. O'Connor  S. J. Connor  M. P. Sparrow  P. Bampton  A. J. Walsh  J. M. Andrews  Australian Inflammatory Bowel Disease Association
Affiliation:1. Inflammatory Bowel Disease Service, Department of Gastroenterology and School of Medicine, University of Adelaide at Royal Adelaide Hospital, Adelaide, South Australia, Australia;2. Department of Gastroenterology, St Vincent's Hospital, Sydney, New South Wales, Australia;3. Department of Gastroenterology, The Alfred Hospital, Melbourne, Victoria, Australia;4. Department of Gastroenterology, Liverpool Hospital, Sydney, New South Wales, Australia;5. Department of Gastroenterology, Princess Alexandra Hospital, Brisbane, Queensland, Australia;6. Department of Gastroenterology, Flinders Medical Centre, Adelaide, South Australia, Australia
Abstract:
Keywords:ulcerative colitis  tumour necrosis factor‐α    inflammatory bowel disease  monoclonal antibody  colectomy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号